These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6174070)

  • 1. [Inhibition of NK activity by oses: effect of interleukin 2 (author's transl)].
    Vie H; Ythier A; Moreau JF; Peyrat MA; Soulillou JP
    Ann Immunol (Paris); 1981; 132C(3):327-37. PubMed ID: 6174070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human natural killer activity by 2-deoxy-D-glucose and other sugars.
    Schlesinger M; Bekesi JG
    J Clin Lab Immunol; 1984 Sep; 15(1):19-26. PubMed ID: 6512844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of NK activity and antibody-dependent cellular cytotoxicity of lymphocytes by human tumor clonogenic assay--its correlation with the 51Cr-release assay.
    Nomori H; Saijo N; Fujita J; Hyoi M; Sasaki Y; Shimizu E; Kanzawa F; Inomata M; Hoshi A
    Int J Cancer; 1985 Apr; 35(4):449-55. PubMed ID: 3872846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
    Vie H; Bonneville M; Sondermeyer P; Moreau JF; Soulillou JP
    Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the cellular cytotoxic activities of colostral lymphocytes and maternal peripheral blood lymphocytes.
    Nair MP; Schwartz SA; Slade HB; Johnson MZ; Quebbeman JF; Beer AE
    J Reprod Immunol; 1985 May; 7(3):199-213. PubMed ID: 2410614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
    Gersuk GM; Chang WC; Pattengale PK
    J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
    Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
    Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on natural, antibody-dependent, and interleukin-2-activated killer-cell activity of a patient with mucolipidosis III as a test of the mannose-6-phosphate lytic acceptor hypothesis.
    Werkmeister JA; Pross HF
    J Clin Immunol; 1985 Jul; 5(4):228-38. PubMed ID: 2931446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K; Tilden AB; Balch CM
    J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
    Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of activity of human NK and K cells by simple sugars: discrimination between binding and postbinding events.
    Ortaldo JR; Timonen TT; Herberman RB
    Clin Immunol Immunopathol; 1984 Jun; 31(3):439-43. PubMed ID: 6713745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.